These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 14726104)
1. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants. Mueller XM Ann Thorac Surg; 2004 Jan; 77(1):354-62. PubMed ID: 14726104 [TBL] [Abstract][Full Text] [Related]
2. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389 [No Abstract] [Full Text] [Related]
3. Optimizing the immunosuppressive regimen in heart transplantation. Eisen H; Ross H J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807 [TBL] [Abstract][Full Text] [Related]
4. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. Bush WW AACN Clin Issues; 1999 May; 10(2):253-69; quiz 304-6. PubMed ID: 10578712 [TBL] [Abstract][Full Text] [Related]
5. [Immunosuppression for kidney transplant recipients: current strategies]. Alberú J; Urrea EM Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061 [TBL] [Abstract][Full Text] [Related]
6. [Immunossupresive drugs in renal transplantation]. Baczkowska T; Durlik M Pol Arch Med Wewn; 2004 Oct; 112 Spec No():99-120. PubMed ID: 15669207 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapies after heart transplantation--The balance between under- and over-immunosuppression. Söderlund C; Rådegran G Transplant Rev (Orlando); 2015 Jul; 29(3):181-9. PubMed ID: 25812489 [TBL] [Abstract][Full Text] [Related]
8. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients. Itescu S; Burke E; Lietz K; John R; Mancini D; Michler R; Rose E; Oz M; Edwards N Circulation; 2002 Mar; 105(10):1214-9. PubMed ID: 11889016 [TBL] [Abstract][Full Text] [Related]
9. Current State of Immunosuppression: Past, Present, and Future. Karam S; Wali RK Crit Rev Eukaryot Gene Expr; 2015; 25(2):113-34. PubMed ID: 26080606 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppression: towards a logical approach in liver transplantation. Perry I; Neuberger J Clin Exp Immunol; 2005 Jan; 139(1):2-10. PubMed ID: 15606606 [TBL] [Abstract][Full Text] [Related]
11. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386 [TBL] [Abstract][Full Text] [Related]
12. The management of immunosuppression: the art and the science. Mancini MC; Cush EM; Launius BK; Brown PA Crit Care Nurs Q; 2004; 27(1):61-4. PubMed ID: 14974524 [TBL] [Abstract][Full Text] [Related]